Strategists at HSBC led by Frank Lee lowered their price target on the shares to $110 from $200 and cut the rating to Reduce ...

While Micron's partnership with NVIDIA boosts its AI prospects, short-term challenges, including weak consumer spending and ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Shares of Absci on Wednesday jumped following a report on a $20 million investment from Advanced Micro Devices. The stock was up 27% to $3.89 in pre-market trading. Through Tuesday's close, shares ...

Absci (NASDAQ:ABSI) was rising after a media report about the semiconductor company Advanced Micro Devices (NASDAQ:AMD) ...

HSBC analyst Frank Lee sees that trend continuing, and lowered his price target on AMD shares by $90, to $110 per share, and ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries.

Dell Technologies (NYSE: DELL) builds on decades of PC innovation with a new, simplified portfolio featuring on-device AI for ...

Dell’s embrace of AMD for corporate PCs — it already uses the chipmaker for consumer devices — is another blow for Intel Corp ...

Detailed price information for Adv Micro Devices (AMD-Q) from The Globe and Mail including charting and trades.

All part of the brand’s desire to “transform screens into adaptive, intelligent companions that simplify and enrich every day ...

In an internal test, AMD used the Ryzen AI Max+ 395 to run a version of the Llama 70B large language model. The company says ...